Cancer Research UK’s Drug Discovery Committee has awarded the Northern Institute of Cancer Research £5M to bring more cancer drugs to clinic trials.
NICE says it cannot give a positive decision over whether to recommend a new drug for ovarian cancer unless its makers provide more information on cost.
Combining chemotherapy with new drugs that target a protein that helps cancer cells to withstand chemotherapy could drastically improve treatment
Cancer Research UK and Cancer Research Technology announce partnership with Monopar Therapeutics to develop new oncology compound
Cancer Research UK, Cancer Research Technology (CRT) and Monopar Therapeutics LLC will take forward an antibody treatment HuATN-658 into clinical trials.
A UK-led trial has found that combining a chemotherapy drug with hormone treatment extended the lives of men with advanced prostate cancer.
Researchers have developed an experimental treatment to overcome resistance to drugs used to treat cancers of the blood.
Researchers in Edinburgh have discovered how a molecular mechanism drives the growth of bile duct cancer.
Cancer Research UK scientists have taken steps to overcome drug resistance in glioblastoma, the most common type of brain tumour in adults.
US researchers have found that combining conventional therapy with an experimental cancer drug helped overcome drug resistance in breast cancer cells.
A new drug – crizotinib (Xalkori) – may be more beneficial than chemotherapy for some lung cancer patients.